- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Essential Thrombocythaemia Myelofibrosis
Total 1183 results
-
National Cancer Institute (NCI)CompletedPrimary Myelofibrosis | Polycythemia Vera | Essential Thrombocythemia | Chronic Myelomonocytic Leukemia | Accelerated Phase Chronic Myelogenous Leukemia | Relapsing Chronic Myelogenous Leukemia | Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative | Philadelphia Chromosome Negative Chronic Myelogenous... and other conditionsUnited States
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.RecruitingModerate and High Risk MyelofibrosisChina
-
Novartis PharmaceuticalsTerminatedMyelofibrosis With High Molecular Risk MutationsBelgium, Spain, United Kingdom, Hungary, Italy, Japan, Taiwan, Germany, Canada, Singapore, Austria, Australia, France, Israel, Sweden, Switzerland, Hong Kong, Greece, Turkey, Brazil, Russian Federation, Denmark, Portugal, Norway, Poland
-
CelgeneCompletedPrimary Myelofibrosis | MPN-associated MyelofibrosisUnited States, Netherlands, France, Australia, Italy, United Kingdom, Canada, Germany, China, Spain, Belgium, Austria, Poland, Sweden, Japan, Russian Federation
-
AbbVieActive, not recruitingMyelofibrosis (MF)United States, Australia, Canada, Croatia, Greece, Hungary, Israel, Italy, Japan, Korea, Republic of, Puerto Rico, Spain, United Kingdom, Taiwan
-
National Cancer Institute (NCI)Active, not recruitingPrimary Myelofibrosis | Secondary MyelofibrosisUnited States
-
Mayo ClinicNational Cancer Institute (NCI)Active, not recruitingPrimary Myelofibrosis | Secondary MyelofibrosisUnited States
-
Mayo ClinicNational Cancer Institute (NCI)CompletedPrimary Myelofibrosis | Anemia | Secondary MyelofibrosisUnited States
-
Mayo ClinicNational Cancer Institute (NCI)CompletedChronic Myeloproliferative Disorders | Secondary Myelofibrosis
-
Mayo ClinicNational Cancer Institute (NCI)TerminatedChronic Myeloproliferative Disorders | Secondary MyelofibrosisUnited States
-
Mayo ClinicNational Cancer Institute (NCI)TerminatedChronic Myeloproliferative Disorders | Secondary MyelofibrosisUnited States
-
The First Affiliated Hospital of Xiamen UniversityRecruitingPrimary MyelofibrosisChina
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Recruiting
-
Qilu Hospital of Shandong UniversityRecruiting
-
Geron CorporationRecruiting
-
Assistance Publique - Hôpitaux de ParisNot yet recruiting
-
Geron CorporationRecruitingMyelofibrosisUnited States, Australia, Italy, India, United Kingdom, Israel, Taiwan, Poland, Malaysia, Argentina, Spain, Turkey, Belgium, Germany, Austria, Brazil, Bulgaria, Colombia, Denmark, France, Georgia, Hungary, Korea, Republic of, Portugal, ... and more
-
Novartis PharmaceuticalsActive, not recruitingMyelofibrosisUnited Kingdom, Australia, Canada, Switzerland, Netherlands, Spain, Germany, Italy, Turkey, Russian Federation, Sweden, Denmark, Hungary
-
Galecto Biotech ABOPIS s.r.lActive, not recruitingMyelofibrosisGermany, Italy, United States, Australia
-
Novartis PharmaceuticalsTerminatedPrimary MyelofibrosisSpain, Germany, Italy
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI); Incyte CorporationActive, not recruitingPrimary Myelofibrosis | Secondary MyelofibrosisUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedPrimary Myelofibrosis | Secondary MyelofibrosisUnited States
-
Cellenkos, Inc.Recruiting
-
Suzhou Zelgen Biopharmaceuticals Co.,LtdRecruiting
-
Bristol-Myers SquibbActive, not recruitingMyelofibrosisItaly, Spain, United States, Australia, France, Germany, Greece, Hungary, Israel, Korea, Republic of, Poland, Romania
-
French Innovative Leukemia OrganisationCompleted
-
PharmaMarCompletedMyelofibrosisUnited States, Italy
-
M.D. Anderson Cancer CenterCelgene CorporationCompleted
-
Universidade Federal de Santa MariaCompletedHealthy Volunteers | Hypertension, EssentialBrazil
-
First Affiliated Hospital of Zhejiang UniversityZhejiang Cancer Hospital; First People's Hospital of Hangzhou; Second Affiliated... and other collaboratorsRecruiting
-
University Hospital, AngersNot yet recruiting
-
Bristol-Myers SquibbRecruiting
-
The University of Hong KongImago BioSciences,Inc.Recruiting
-
Center for International Blood and Marrow Transplant...National Cancer Institute (NCI); National Institutes of Health (NIH); National...RecruitingMyelofibrosisUnited States
-
Karyopharm Therapeutics IncActive, not recruitingMyelofibrosisSpain, China, Poland, United States, France, Greece, Italy
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedMyelofibrosisUnited States
-
Suzhou Zelgen Biopharmaceuticals Co.,LtdCompleted
-
Suzhou Zelgen Biopharmaceuticals Co.,LtdCompletedMyelofibrosisChina
-
Stichting Hemato-Oncologie voor Volwassenen NederlandCTI BioPharma; Dutch Cancer SocietyActive, not recruitingMyelofibrosisNetherlands, Belgium
-
Qilu Hospital of Shandong UniversityCompleted
-
Geron CorporationCompletedMyelofibrosisUnited States, France, Italy, United Kingdom, Belgium, Germany, Taiwan, Spain, Israel, Korea, Republic of, Canada
-
CTI BioPharmaSGS S.A.CompletedMyelofibrosisMoldova, Republic of, Germany
-
Hoffmann-La RocheCompletedMyelofibrosisItaly, United States, Canada, Germany
-
M.D. Anderson Cancer CenterCelgene CorporationCompleted
-
University of UtahM.D. Anderson Cancer Center; Baylor College of Medicine; Fred Hutchinson Cancer...Completed
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingSecondary MyelofibrosisUnited States
-
CelgeneCompletedMyelofibrosis | Myeloid Metaplasia | Myelofibrosis With Myeloid MetaplasiaUnited States, Italy, United Kingdom, Austria, Spain
-
Addpharma Inc.Completed